The Atg16L1 risk variant (Atg16L1T300A), was found to influence the risk of IBD, creating a caspase cleavage site that weakens the stability of the protein, thereby diminishing autophagy, particularly in the presence of TNF-α (143). This evidence concerns the gene ATG16L1 and inflammatory bowel disease.